Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 4/20 | 0.35 |
| ▸ | CA2 | P00918 | 4/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3403215 | 0.98 | KDM4E (0.43) | KDM4EALDH1A1RAB9ALMNASMN1; SMN2 | |
| SCHEMBL4049889 | 0.89 | CALM1 (0.39) | KDM4EALDH1A1RAB9ALMNASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL20191168 | 0.80 | TP53 (0.43) | KDM4EALDH1A1RAB9ALMNASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL28388643 | 0.76 | KDM4E (0.37) | KDM4EALDH1A1RAB9ALMNASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL9696543 | 0.76 | KDM4E (0.43) | KDM4EALDH1A1RAB9ALMNASMN1; SMN2 | |
| SCHEMBL5292833 | 0.75 | EEF2K (0.38) | KDM4EALDH1A1RAB9ALMNASMN1; SMN2 | |
| SCHEMBL5711144 | 0.74 | KDM4E (0.41) | KDM4EALDH1A1RAB9ALMNASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL9238990 | 0.74 | TAAR1 (0.38) | ALDH1A1LMNASMN1; SMN2HTTTAAR1 | |
| Hydrochloric Acid SCHEMBL1457612 | 0.73 | TAAR1 (0.42) | KDM4EALDH1A1LMNASMN1; SMN2HTT | |
| Iodide SCHEMBL5543786 | 0.73 | EEF2K (0.40) | KDM4EALDH1A1RAB9ALMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2249832-A1 | METHOD FOR TREATING FIBROSIS AND CANCER WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS | Agency for Science, Technology And Research (SG) | 2010-11-17 | — | — | EP | disclosed |
| WO-2009096905-A1 | METHOD FOR TREATING FIBROSIS AND CANCER WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2009-08-06 | — | — | WO | disclosed |